VYGR - Voyager Therapeutics stock falls 9% on public offering of its stock
2024-01-04 16:26:56 ET
More on Voyager Therapeutics
- Voyager stock surges on ~$1.3B licensing deal with Novartis for Huntington's candidate
- Voyager Therapeutics Non-GAAP EPS of -$0.59 beats by $0.01, revenue of $4.61M beats by $1.7M
- Seeking Alpha’s Quant Rating on Voyager Therapeutics
For further details see:
Voyager Therapeutics stock falls 9% on public offering of its stock